Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Summary

The purpose of this study is to assess the Safety and Efficacy of IONIS-FB-Lrx for up to 120 patients with Geographic Atrophy secondary to Age Related Macular Degeneration

Timeline

Start

2018-03-16

Primary completion

2018-10-10

Completion

2018-10-10

Outcome

Outcome not reported

Stopped (Business): “Business objective change, no safety or efficacy concerns”

Drugs

Indications